Anal cancer

Our researchers in the Japanese city of Nagoya discovered an enzyme against anal cancer.
The cancers of the anus are predominantly squamous cell carcinomas.
In 2020, 2,910 people developed anal cancer, including 1,895 women.
While in colon cancer the trend is decreasing, both, the incidence and death rates in anal cancer have risen significantly internationally over the past 15 years.
The survival rate for anal cancer over a five-year period is 65 percent for women and 61 percent for men.
We recommend taking one capsule twice a day.